Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
3.365
-0.155 (-4.40%)
Nov 21, 2024, 2:54 PM EST - Market open
Ironwood Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -2.46 | -1,002 | 175.07 | 528.45 | 106.18 | 21.51 | Upgrade
|
Depreciation & Amortization | 2.04 | 1.58 | 1.42 | 1.52 | 2.36 | 5.58 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.08 | - | 0 | 0.09 | 0.47 | 0.15 | Upgrade
|
Asset Writedown & Restructuring Costs | 5 | 1,095 | - | - | 1.2 | - | Upgrade
|
Stock-Based Compensation | 33.99 | 32.01 | 27.05 | 22.28 | 31.18 | 31.28 | Upgrade
|
Other Operating Activities | 59.73 | 45.36 | 67.41 | -308.18 | 28.39 | 40.85 | Upgrade
|
Change in Accounts Receivable | 48.34 | 0.92 | 7.99 | 7.71 | 4.09 | -68.89 | Upgrade
|
Change in Inventory | - | - | - | - | 0.65 | - | Upgrade
|
Change in Accounts Payable | -27 | 12.38 | -8.12 | -2.64 | -7.52 | -32.7 | Upgrade
|
Change in Unearned Revenue | - | - | - | - | -0.88 | 0.88 | Upgrade
|
Change in Other Net Operating Assets | 4.47 | -2.03 | 2.94 | 12.66 | 2.72 | 0.73 | Upgrade
|
Operating Cash Flow | 124.17 | 183.43 | 273.76 | 261.9 | 168.84 | 10.73 | Upgrade
|
Operating Cash Flow Growth | -45.25% | -33.00% | 4.53% | 55.12% | 1474.23% | - | Upgrade
|
Capital Expenditures | -0.35 | -0.27 | -0.14 | -0.27 | -1.84 | -7.19 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | - | - | - | 0.27 | Upgrade
|
Cash Acquisitions | -3.98 | -1,026 | - | - | - | - | Upgrade
|
Other Investing Activities | - | - | - | - | - | -4.22 | Upgrade
|
Investing Cash Flow | -4.33 | -1,026 | -0.14 | -0.27 | -1.84 | -11.14 | Upgrade
|
Long-Term Debt Issued | - | 400 | - | - | - | 400 | Upgrade
|
Long-Term Debt Repaid | - | -100 | -120.7 | - | - | -383.75 | Upgrade
|
Net Debt Issued (Repaid) | -125 | 300 | -120.7 | - | - | 16.25 | Upgrade
|
Issuance of Common Stock | 11.81 | 6.36 | 9.54 | 19.58 | 18.55 | 13.6 | Upgrade
|
Repurchase of Common Stock | -0.74 | - | -126.39 | -24.13 | - | - | Upgrade
|
Other Financing Activities | -29.06 | -29.2 | - | - | - | -31.03 | Upgrade
|
Financing Cash Flow | -142.99 | 277.16 | -237.55 | -4.55 | 18.55 | -1.19 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.1 | -0.05 | - | - | - | - | Upgrade
|
Net Cash Flow | -23.25 | -565.78 | 36.07 | 257.08 | 185.54 | -1.6 | Upgrade
|
Free Cash Flow | 123.82 | 183.15 | 273.63 | 261.63 | 166.99 | 3.54 | Upgrade
|
Free Cash Flow Growth | -45.39% | -33.06% | 4.59% | 56.67% | 4622.68% | - | Upgrade
|
Free Cash Flow Margin | 32.72% | 41.37% | 66.64% | 63.23% | 42.87% | 0.83% | Upgrade
|
Free Cash Flow Per Share | 0.78 | 1.18 | 1.47 | 1.59 | 1.04 | 0.02 | Upgrade
|
Cash Interest Paid | 13.55 | 13.55 | 5.75 | 7.22 | 7.22 | 17.58 | Upgrade
|
Cash Income Tax Paid | 9.95 | 9.95 | 4.62 | 3.45 | 1.85 | - | Upgrade
|
Levered Free Cash Flow | 79.68 | 203.98 | 161.46 | 170.05 | 98.04 | 14.97 | Upgrade
|
Unlevered Free Cash Flow | 100.18 | 217.5 | 166.21 | 189.52 | 116.46 | 37.85 | Upgrade
|
Change in Net Working Capital | -21.12 | -34.24 | 18.58 | -20.85 | 14.18 | 68.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.